Mixed options sentiment in Pfizer (PFE), with shares down 22c near $24.55. Options volume relatively light with 22k contracts traded and calls leading puts for a put/call ratio of 0.2, compared to a typical level near 0.37. Implied volatility (IV30) dropped 0.3 near 26.66,and above the 52wk median, suggesting an expected daily move of $0.41. Put-call skew steepened, indicating increased demand for downside protection.Looking ahead: Pfizer (PFE) will report earnings before the open on 2025-11-04.Option markets are pricing in a 50% probability of a move greater than 3.16% or $0.77.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Pfizer’s Pediatric Ulcerative Colitis Study: A Potential Game-Changer
- Pfizer’s Pediatric Migraine Study: A Potential Game-Changer for Rimegepant
- Pfizer’s Ponsegromab Study: A Potential Game-Changer in Pancreatic Cancer Treatment
- Pfizer’s New Study on Ritlecitinib: A Potential Game-Changer for Chronic Urticaria?
- Pfizer’s Promising Phase 3 Study on Prostate Cancer Treatment: A Market Game-Changer?